Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Nielsen Holdings

Start price
Target price
Perf. (%)
€12.10
19.09.20
-
04.11.21
15.43%
01.12.20

High dividend yield expected
Differentiated customer and product portfolio
Revenue decline/stagnation expected
Little innovation
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€91.29
19.09.20
-
04.11.21
16.11%
27.11.20

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€61.25
19.09.20
-
04.11.21
110.20%
05.11.21

Could be worthwhile Investment >10% per year
buy
Grenke AG

Start price
Target price
Perf. (%)
€34.18
19.09.20
-
04.11.21
-3.10%
11.03.21

Could be worthwhile Investment >10% per year
buy
Immunomedics Inc.

Start price
Target price
Perf. (%)
€72.02
19.09.20
-
04.11.21
3.10%
05.11.21

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
29.09.20
72.97%
29.09.20

High risks for its business
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.00
19.09.20
-
04.11.21
-26.89%
05.11.21

Could be worthwhile Investment >10% per year
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€148.38
19.09.20
-
20.10.20
15.57%
20.10.20

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€148.38
19.09.20
-
20.10.20
15.57%
20.10.20

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€148.38
19.09.20
-
20.10.20
15.57%
20.10.20

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Apple Inc.

Start price
Target price
Perf. (%)
€90.01
19.09.20
-
20.10.20
10.23%
20.10.20

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
buy
Apple Inc.

Start price
Target price
Perf. (%)
€90.01
19.09.20
-
20.10.20
10.23%
20.10.20

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
buy
Apple Inc.

Start price
Target price
Perf. (%)
€90.01
19.09.20
-
20.10.20
10.23%
20.10.20

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
buy
Apple Inc.

Start price
Target price
Perf. (%)
€90.01
19.09.20
-
20.10.20
10.23%
20.10.20

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Grenke AG

Start price
Target price
Perf. (%)
€34.18
19.09.20
-
06.10.20
24.40%
06.10.20

Risky Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
23.09.20
34.46%
23.09.20

Could be very worthwhile Investment >20% year
buy
ConAgra Foods Inc.

Start price
Target price
Perf. (%)
€29.31
19.09.20
-
04.11.21
2.92%
20.11.20

EBIT growth >5% per year expected
Revenue growth >5% per year expected
High dividend yield expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€91.07
18.09.20
-
04.11.21
21.05%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€91.07
18.09.20
-
04.11.21
21.05%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€91.07
18.09.20
-
04.11.21
21.05%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€91.07
18.09.20
-
04.11.21
21.05%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
buy
Commerzbank AG

Start price
Target price
Perf. (%)
€4.55
18.09.20
€7.00
19.09.20
-1.12%
19.09.20

Could be worthwhile Investment >10% per year
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€16.98
17.09.20
€55.00
04.11.21
339.05%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€16.98
17.09.20
€55.00
04.11.21
339.05%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Grenke AG

Start price
Target price
Perf. (%)
€33.98
17.09.20
-
05.10.20
9.89%
05.10.20